Results 271 to 280 of about 1,472,414 (411)
ABSTRACT Introduction/Aims Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant multisystem disorder that occurs worldwide. The most common mutation in the United States, V142I, has previously been described as having a primarily cardiac presentation.
Urvi Desai+3 more
wiley +1 more source
Antihypertensive Drug Amlodipine Besylate Shows Potential in Alleviating Diabetic Peripheral Neuropathy. [PDF]
Wei Y+12 more
europepmc +1 more source
Prevalence of monoclonal protein in peripheral neuropathy [PDF]
Jeffrey Steier, W. Neath Folger
openalex +1 more source
ABSTRACT Introduction/Aims Pacinian corpuscles are end organs of the sensory nervous system. The size and superficial location of Pacinian corpuscles allows them to be visualized with high‐resolution ultrasound. This pilot study sought to assess the reliability of Pacinian corpuscle counting in the hand using ultrasound.
Nicholas J. Miller+3 more
wiley +1 more source
Unleashing the Power of Multiomics: Unraveling the Molecular Landscape of Peripheral Neuropathy. [PDF]
Choi J+7 more
europepmc +1 more source
Drug points: Peripheral neuropathy with bezafibrate [PDF]
Carol Ellis, William Wallis, M. Caruana
openalex +1 more source
Frequency of Guillain‐Barré Syndrome During the COVID‐19 Pandemic: A Multicenter Study
ABSTRACT Introduction/Aims The incidence of Guillain‐Barré syndrome (GBS) during the COVID‐19 pandemic varies according to country. We investigated the changes in the number of patients with GBS and their characteristics who were reported in Tokyo in 2020 at the beginning of the COVID‐19 pandemic, compared to those two years prior.
Toshiyuki Hayashi+14 more
wiley +1 more source
Peripheral Neuropathy Secondary to a Functional Vitamin B12 Deficiency in the Setting of Erythrocytosis. [PDF]
McDevitt LW, Choppa A, Paracha A, Zhu X.
europepmc +1 more source
Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides [PDF]
J C Brouet+3 more
openalex +1 more source
ABSTRACT Introduction/Aims Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a potentially disabling autoimmune neuropathy. Approximately 20% of patients are refractory to first‐line treatments necessitating second‐line options with limited evidence and potential adverse effects.
Shamim Miah+6 more
wiley +1 more source